Lead Investigator: Toshifumi Kishimoto, Nara Medical University
Title of Proposal Research: Development of the optimal treatment of Nalmefene in patients with alcohol dependence
Vivli Data Request: 7323
Funding Source: None
Potential Conflicts of Interest: None
Summary of the Proposed Research:
Identifying who among alchohol dependence (AD) patients or problem drinkers, is best suited for Nalmefene treatment and has the greatest likelihood to control drinking. The current study and knowledege might contribute to the optimization of pharmacotherapy and the improvement of the quality of life for alcoholism and public health.
Requested Studies:
A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
Data Contributor: Otsuka Pharmaceuticals
Study ID: NCT02364947
Sponsor ID: 339-14-001